BrainStorm Cell Therapeutics Inc. (BCLI) KPIs and segments

BCLIOTCBiological Products, (No Diagnostic Substances)Fiscal year ends December 31

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026Score 0/30

$0.77−0.01 (-1.17%)

Close on Oct 19, 2026Market cap $8.50MP/E –Yield –

KPIs & segments

Operating metrics and segments that drive BrainStorm Cell Therapeutics's business

Coming soon

This tab will track the numbers specific to BrainStorm Cell Therapeutics's business model — such as store count, revenue by banner, revenue per store and new openings — taken from filings and earnings releases.

See a number that looks wrong?